estimated revenue glp-1 drugs Agonists Weight Loss Market Report, 2025-2030 GLP-1 Receptor Agonist Market Size

GLP-1 agonist drugs, often called GLP-1s, are injectable medications that work by mimicking the GLP-1 hormone that your small intestine makes in response to food

In recent years, the gut-brain axis has been increasingly considered a promising topic for the study of CNS-related diseases because the gut microbiota and gut hormones have been shown to interact with other organs including the brain (Knight et al., 2017), although the mechanisms involved in gut homeostasis and brain function are as yet uncharacterized (Neufeld and Foster, 2009)

The SGLT2 Comparison Was More Complicated The comparison against SGLT2 inhibitors is especially valuable because it places GLP-1 receptor agonists against another modern metabolic drug class rather than older diabetic therapies

With a range of Weight Management, Medical Condition, Detox Plans, and Face Yoga Plans, the app also provides premium health trackers, recipes and health content